<ѻýҕl>Closing Colorectal Cancer Screening Gaps With FIT Initiativeѻýҕl> VA hospital meets goal of increasing monthly screenings to address backlog from pandemic Sep 19, 2022
<ѻýҕl>Radiation Oncology Residents Report Deficits in Training During the Pandemicѻýҕl> About half worry about job prospects Sep 19, 2022
<ѻýҕl>How a Dedicated Bone Marrow Biopsy Clinic Eased Wait Timesѻýҕl> VA center in Cleveland got program up and running in about a month Sep 19, 2022
<ѻýҕl>Clinical Decision Tool Cuts Inappropriate BMA Therapy in Prostate Cancerѻýҕl> Study at VA center shows better disease-related bone healthcare Sep 18, 2022
<ѻýҕl>IV Iron Replacements Go Head-to-Head for IBD-Related Anemiaѻýҕl> Trial confirms higher rate of hypophosphatemia with ferric carboxymaltose Sep 16, 2022
<ѻýҕl>Is Cancer Therapy Also a Lupus Cure?ѻýҕl> Patients in pilot study show months-long complete remission Sep 15, 2022
<ѻýҕl>Hand Cooling, Compression Both Effective for Nerve Pain in Breast Cancerѻýҕl> But access, cost, and tolerability may favor the latter option, said researcher Sep 14, 2022
<ѻýҕl>Potential Practice-Changer for Refractory Metastatic Colon Cancerѻýҕl> Significant survival gain with fruquintinib in patients with heavily pretreated disease Sep 14, 2022
<ѻýҕl>Non-Chemo Regimen Led to High Response Rates in Cisplatin-Ineligible Bladder Cancerѻýҕl> "Encouraging activity" with enfortumab vedotin-pembrolizumab in patients with high unmet need Sep 14, 2022
<ѻýҕl>Long-Term ADT With Radiation Helps Prevent Post-Prostatectomy Metastasesѻýҕl> However, no benefit seen with short-term hormone therapy versus radiotherapy alone Sep 13, 2022
<ѻýҕl>Denosumab Halts Bone Loss From Ovarian Suppression, AIs for Breast Cancerѻýҕl> Areal BMD increased when given at the start of maximal estradiol depletion therapy Sep 13, 2022
<ѻýҕl>Neoadjuvant Anti-PD-1 Strategy Prevails Over Adjuvant in Resectable Melanomaѻýҕl> Large increase in event-free survival with neoadjuvant plus adjuvant versus only adjuvant therapy Sep 13, 2022
<ѻýҕl>KRAS Inhibitor Tops Docetaxel for Previously Treated NSCLCѻýҕl> "New second-line standard" in KRAS G12C-mutant disease, says study investigator Sep 13, 2022
<ѻýҕl>Triplet in First-Line Kidney Cancer Thwarts Disease Progressionѻýҕl> Randomized study shows "clinically meaningful" PFS improvement over dual immunotherapy alone Sep 13, 2022
<ѻýҕl>Survival Bump in Unfit NSCLC With First-Line Immunotherapyѻýҕl> Atezolizumab doubles OS at 2 years versus chemotherapy in those ineligible for platinum doublets Sep 12, 2022
<ѻýҕl>Neoadjuvant Cemiplimab Active in Resectable Cutaneous Squamous Cell Carcinomaѻýҕl> Pathologic complete responses seen in 63% of patients in phase II data Sep 12, 2022
<ѻýҕl>Three Adjuvant Immunotherapy Trials Flop in Renal Cell Carcinomaѻýҕl> Studies appear to contradict benefit previously shown with pembrolizumab in this setting Sep 12, 2022
<ѻýҕl>Colorectal Cancer Burden on the Rise in Developed Countriesѻýҕl> Global study predicts an uptick in incidence and mortality through 2040 Sep 12, 2022
<ѻýҕl>Combination Therapy Shows Promise for NSCLC That Progresses on Osimertinibѻýҕl> About half of patients responded to tepotinib plus osimertinib, but efficacy ceiling persists Sep 12, 2022
<ѻýҕl>'Striking' Colon Cancer Data Spur Mid-Presentation Ovation at ESMOѻýҕl> Preoperative immunotherapy combo in dMMR disease yields major pathologic response in 95% Sep 12, 2022
<ѻýҕl>Tumor Infiltrating Lymphocytes Reemerge as Potential Melanoma Optionѻýҕl> More than 50% increase in 6-month PFS versus ipilimumab after progression on first-line anti-PD-1 Sep 12, 2022
<ѻýҕl>Add-On Pembrolizumab Misses in Locally Advanced Head and Neck Cancerѻýҕl> Post hoc data point to possible benefit in patients with higher PD-L1 levels Sep 11, 2022
<ѻýҕl>Locking Down a Link Between Pollution and EGFR-Mutated Lung NSCLCѻýҕl> Study also shed lights on what may lead to lung cancer in never smokers Sep 11, 2022
<ѻýҕl>'Potential New Standard' for Progressing Desmoid Tumorsѻýҕl> Risk of disease progression or death reduced by 71% with oral gamma secretase inhibitor Sep 10, 2022
<ѻýҕl>Targeted Combo Flops as First-Line Treatment in Advanced Breast Cancerѻýҕl> No clinical benefit boost with anti-CD73 oleclumab added to durvalumab and chemo Sep 10, 2022
<ѻýҕl>Maintenance PARP Inhibition Boosts OS in Two Ovarian Cancer Trialsѻýҕl> Results from SOLO-1 and PAOLA-1 show "clinically meaningful" long-term results with olaparib Sep 09, 2022
<ѻýҕl>Worse OS With Rucaparib First in Trial of Recurrent, BRCA+ Ovarian Cancerѻýҕl> A closer look at why PARP inhibitor's third-line indication was withdrawn Sep 09, 2022
<ѻýҕl>Antibody-Drug Conjugate Prolongs Survival in Metastatic Breast Cancerѻýҕl> Positive outcome with sacituzumab govitecan leads to questions about ADC sequencing Sep 09, 2022
<ѻýҕl>Robotic Surgery Tops Laparoscopic Surgery for Middle and Low Rectal Cancerѻýҕl> Randomized trial shows fewer positive circumferential resection margins with robotic technique Sep 09, 2022
<ѻýҕl>CAR-T Therapy Effective in Youngest Kids With ALLѻýҕl> Analysis shows safety and outcomes equivalent to those reported in older children Sep 08, 2022
<ѻýҕl>Study: Microwave Ablation for Lung Nodules Effective as Last Resortѻýҕl> Good option for patients who can't have surgery or radiotherapy, surgeon says Sep 08, 2022
<ѻýҕl>Rezvilutamide Bests Bicalutamide in Metastatic Prostate Cancerѻýҕl> Combined with ADT, the androgen-receptor inhibitor significantly improved OS, radiographic PFS Sep 07, 2022
<ѻýҕl>Coping With a Deadly Prognosisѻýҕl> An impossible battle with the rarest of cancers Sep 06, 2022 podcast
<ѻýҕl>Jane Fonda's Non-Hodgkin Lymphomaѻýҕl> The award-winning actress opened up about her latest health news Sep 06, 2022
<ѻýҕl>Keytruda Plus T-VEC Falls Short in Unresectable Melanomaѻýҕl> No significant survival benefit with combination, but certain patients lived longer Sep 02, 2022
<ѻýҕl>A Light at the End of the Tunnel for Low-Risk Prostate Cancer?ѻýҕl> The MUSIC model might improve quality of life and prevent overtreatment Sep 02, 2022
<ѻýҕl>10-Year Follow-Up Confirms Benefit of Chemoradiotherapy in MIBC Patientsѻýҕl> Findings "supported a change in clinical practice" Sep 01, 2022
<ѻýҕl>Does PARP Inhibitor Maintenance Induce Platinum Resistance in Ovarian Cancer?ѻýҕl> Shorter progression-free interval with platinum chemotherapy after olaparib maintenance Sep 01, 2022
<ѻýҕl>2 Years of Endocrine Therapy, 2 Decades of Protection From Metastatic Breast Cancerѻýҕl> Tamoxifen protects low-risk premenopausal patients, goserelin helps high-risk patients Aug 31, 2022
<ѻýҕl>Trainees May Miss More Sessile Serrated Polyps on Colonoscopyѻýҕl> But resident or fellow involvement didn't have a negative impact on other key quality indicators Aug 31, 2022